Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12049624 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature